In This Week’s Edition: |
|
|
|
|
|
FSIS Updates Guidance on Regulation and Labeling Meal KitsThe guidance is updated in the following ways:
FDA Issues Final Rule on Unapproved Animal Drug Residues in FoodThe rule establishes procedures by which FDA may establish, amend, or revoke tolerances for residues of new animal drugs in any edible portion of any animal imported into the United States (import tolerances). These import tolerances provide a basis for the legal marketing of such animal-derived food. USDA Takes Steps to Build More Sustainable, Resilient and Inclusive Food SystemsAt the United Nations Food Systems Summit this week, USDA highlighted $5 billion in planned investments and several steps it has taken to advance the goals of ending hunger and malnutrition and building more sustainable, resilient and inclusive food systems. FDA CORE Outbreak Investigation Status UpdateThis week’s updates are:
FDA Takes Steps to Improve Quality and Safety of SunscreensFDA has proposed revisions and updates to requirements related to maximum sun protection factor (SPF) values, active ingredients, broad spectrum requirements, and product labeling, among other provisions. USDA Announces Intent to Establish an Equity Commission, Solicits Nominations for MembershipUSDA will establish an Equity Commission and is requesting nominations for membership on the Equity Commission Advisory Committee and Equity Commission Subcommittee on Agriculture. This action represents a step towards implementing President Biden’s commitment to create an Equity Commission and the American Rescue Plan Act provision that directs USDA to “address historical discrimination and disparities in the agriculture sector… [through] one or more equity commissions to address racial equity issues within USDA and its programs.” FSIS Updates Lists of Foreign Establishments Eligible to Export to U.S. |
|
FDA Import AlertsThe latest FDA import alerts include FSVP, color additives, seafood, canned foods, and more. Warning LettersLaboratorio Pharma International SRL CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated Nanomateriales Químicos Avanzados, S.A. de C.V. CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated Fibromyalgia Treatment Group – FTG, LLC New Drug/Misbranded Foreign Supplier Verification Program (FSVP) |
